Beata P. P.
- Country
- Poland
- Department
- 40877: Dermatology
Research Overview
- Phase 3 Randomized Double-Blind Study of NT 201 vs. Placebo in Adults with Moderate to Severe Platysma Prominence
- A phase 3, randomized, double-blind, placebo-controlled, multicenter study with open-label extension to evaluate the efficacy and safety of bimekizumab in study participants with palmoplantar pustulosis
Data & Insights
Has run more than one trial at 2 of 83 partner sites.
Specializations
Atopic dermatitis and chronic eczematous disease
Beata Polkowska-Pruszyńska is involved in clinical research focused on atopic dermatitis, including moderate to severe forms and long-term disease control. Her trial activity also extends to related inflammatory skin conditions such as dermatitis atopic, with attention to therapeutic options for persistent symptom burden.
- Moderate to severe atopic dermatitis
- Long-term disease management
- Eczema-related inflammatory skin disease
Her research landscape includes evaluation of therapies aimed at improving skin inflammation, itch, and overall disease burden in chronic dermatitis.
Chronic urticaria and mast-cell mediated disorders
Her clinical trial involvement includes chronic spontaneous urticaria and chronic urticaria, reflecting interest in recurrent wheal-and-itch disorders driven by persistent immune activation. This area also encompasses treatment evaluation for uncontrolled urticaria symptoms.
- Chronic spontaneous urticaria
- Chronic urticaria
- Urticaria activity and symptom control
Her work in this field is centered on therapies for reducing flare frequency, itch intensity, and disease activity in chronic urticarial conditions.
Vitiligo and pigmentary disorders
Beata Polkowska-Pruszyńska participates in studies on vitiligo, including nonsegmental vitiligo in both adult and pediatric populations. This research domain addresses loss of pigmentation and the restoration of visible skin color in depigmenting disease.
- Nonsegmental vitiligo
- Pediatric vitiligo
- Repigmentation-focused therapy
Her clinical interests include therapies intended to improve pigment recovery and disease control across age groups.
Alopecia areata and autoimmune hair loss
Her trial portfolio includes alopecia areata, with emphasis on severe and pediatric disease. This area focuses on autoimmune scalp hair loss and treatment strategies aimed at hair regrowth and sustained disease suppression.
- Severe alopecia areata
- Pediatric alopecia areata
- Scalp hair regrowth
Her involvement reflects therapeutic interest in restoring hair growth and managing relapsing autoimmune alopecia.
Hidradenitis suppurativa, prurigo nodularis, and other dermatologic indications
Her research also spans hidradenitis suppurativa, prurigo nodularis, palmoplantar pustulosis, and moderate to severe platysma prominence. These studies cover chronic inflammatory skin disease, nodular pruritic dermatoses, pustular psoriasis-spectrum conditions, and aesthetic-corrective facial indications.
- Hidradenitis suppurativa
- Prurigo nodularis
- Palmoplantar pustulosis
- Moderate to severe platysma prominence
Her clinical activity in these areas highlights interest in difficult-to-treat dermatologic disorders with inflammatory and symptom-driven therapeutic needs.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.